Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Mouscron – page 54

1 798 clinical trials in Mouscron, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Mouscron at a glance
1 798
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 798 trials in Mouscron

Open in trial search

Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:EXL01
  • Sponsor:Hospices Civils De Lyon

Study on CAR-T-cell Therapy with Rituximab and Ibrutinib for Patients with High-Risk Mantle Cell Lymphoma

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Klinikum Der Universitat Munchen AöR

Study of Intranasal Sufentanil and Intravenous Morphine for Severe Sickle Cell Pain Crisis in Children

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Sodium Chloride
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:UZ Leuven

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Leonabio Inc.

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Givinostat
  • Sponsor:Italfarmaco S.p.A.

Study of Fluoroestradiol F-18 and Biomarkers for Women with ER-Positive HER2-Negative Metastatic Breast Cancer After CDK4/6 Inhibitor Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluoroestradiol F-18
  • Sponsor:Institut Curie

Pneumonia

Recruiting

Study on Ceftriaxone Dosing for Patients with Severe Community-Acquired Pneumonia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ceftriaxone
  • Sponsor:UZ Leuven

Study on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Institut Gustave Roussy

Study on Protamine Sulfate to Reduce Neurological Events After Aortic Valve Implantation in Patients with Aortic Stenosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Protamine Sulfate
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Mouscron

What the registry says about research in the country

01 Diabetes Prevention Research

Innovative research focusing on glucose intolerance in women with previous gestational diabetes, exploring preventive measures against type 2 diabetes development.

  • Preventive Medicine
  • Endocrinology
  • Women's Health

The study evaluates long-term glycemic control using advanced therapeutic approaches for patients with prediabetes.

02 Oncology Research

Groundbreaking investigation into colon cancer treatment outcomes, examining the potential benefits of common medications in preventing cancer recurrence.

  • Cancer Prevention
  • Gastrointestinal Oncology
  • Survival Studies

The research focuses on improving survival rates for patients with stage II and III colon carcinoma through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.